key: cord-0725210-gh7i952k
authors: Smith, T.; Holm, R. H.; Keith, R. J.; Amraotkar, A. R.; Alvarado, C. R.; Banecki, K.; Choi, B.; Santisteban, I. C.; Bushau-Sprinkle, A. M.; Kitterman, K. T.; Fuqua, J.; Hamorsky, K.; Palmer, K. E.; Brick, J. M.; Rempala, G.; Bhatnagar, A.
title: Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence
date: 2022-05-01
journal: nan
DOI: 10.1101/2022.04.28.22274086
sha: 982915dccc7fc23811308a1bfdf77031849cc70c
doc_id: 725210
cord_uid: gh7i952k

Background: Wastewater-based epidemiology is a promising approach but robust epidemiological models to relate wastewater to community prevalence are lacking. Assessments of SARS-CoV-2 infection rates have relied primarily on convenience sampling, which does not provide reliable estimates of community prevalence because of inherent biases. Methods: From August 2020 to February 2021, we conducted a serial stratified randomized samplings to estimate the prevalence of anti-SARS-CoV-2 antibodies in 3,717 participants, and weekly sampling of community wastewater for SARS-CoV-2 concentrations in Jefferson County, KY. With the use of a Susceptible, Infected, Recovered (SIR)-type model, we obtained longitudinal estimates of prevalence and compared these with wastewater concentration, using regression analysis. Findings: Model analysis revealed significant temporal differences in epidemic peaks; the average incidence rate based on serological sampling in some areas was up to 50% higher than health department rates based on convenience sampling. The model-estimated average prevalence rates correlated well with wastewater (correlation=0.63). In regression analysis, a weekly unit increase in wastewater concentration of SARS-CoV-2 corresponded to an average increase of between 1-1.3 cases of SARS-CoV-2 infection per 100K residents. Interpretation: Publicly available health department incidence rates vastly underestimate true community incidence and wastewater has a high potential to provide robust estimates of community spread of infection. Funding: This work was supported by contracts from the Centers for Disease Control and Louisville-Jefferson County Metro Government, and grants from the James Graham Brown Foundation, the Owsley Brown II Family Foundation, Jewish Heritage Fund and the Center for Predictive Medicine for Biodefense and Emerging Infectious Disease.

Evidence before this study: Administratively reported clinical case rates of coronavirus disease 2019 (COVID- 19) infected individuals are biased due to a wide range of factors from testing access to concerns about missing low and non-symptomatic and self-tested individuals. Wastewater estimates offer an alternative to support community monitoring based on fecal shedding of the virus but are difficult to interpret when compared with the available public health data sets of infection rates. We examined all English literature until February 24, 2022, on Web of Science and PubMed with the terms ["seroprevalence" or "antibody"] AND ["COVID-19" or "SARS-CoV-2"] AND ["wastewater"]. We identified six studies. None of these studies considered randomized COVID-19 community anti-SARS-CoV-2 antibody testing paired with wastewater data.

Added value of this study: The study demonstrates how results from serial stratified randomized serological sampling of the community can be used to build a longitudinal model that can interpolate and extrapolate community levels of infection beyond specific testing dates. Such a model correlates well with wastewater concentrations indicating its utility as a surrogate for infection prevalence. The testing data used in the study were collected before wide availability of COVID-19 vaccines and are therefore unique as they are unlikely to include a significant number of false positive results.

The study demonstrates that convenience sampling obtained data from health department reporting seriously underestimates community-wide prevalence of infection. In contrast, wastewater-based epidemiology may be a faster, costeffective, and more robust method of estimating the prevalence of viral infections within specific urban areas.

Since early in the pandemic, wastewater sampling has emerged as a rapid, convenient, and economical tool to assess the presence and temporal changes in the concentration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in communities. 1 Approximately 34-52% of coronavirus disease 2019 (COVID- 19) infected patients shed SARS-CoV-2 in their feces, up to 16 to 27 days from the onset of symptoms, 2 and can be included in passive, and anonymous, community wastewater monitoring. Thus, wastewater-based epidemiology appears to be a promising new source of community prevalence data but requires a more reliable clinical reference to develop good models. However, due to its limited use prior to COVID-19, there are no established models that relate wastewater data to community prevalence of infection. Although during the COVID-19 pandemic, frequent and wide clinical testing was conducted to estimate the community prevalence of COVID-19, such estimates relied heavily on nonprobability or convenience sampling. Although necessary to readily track infection rates in real time, data from such non-probability sampled population are inherently biased and unlikely to provide reliable estimates of the prevalence and incidence of the infection. 3, 4 Moreover, data from testing only individuals with symptoms are unlikely to gauge prevalence, as many infected individuals show no symptoms, and such data are likely to be always enriched in individuals suspecting infections or experiencing symptoms. Therefore, data reported by local health authorities fail to address meaningfully the need for reliable estimates of spatiotemporal infection, and which account for asymptomatic individuals or individual who have not volunteered for diagnostic testing.

Systematic serological surveys with spatiotemporal resolution offer opportunities for infectious disease surveillance. 5 A systematic assessment of community-wide spread of infection and immunity could be obtained by randomized sampling, and stratified to include individuals of different age, sex, and socioeconomics as well as those living in different geographic areas. 6 In the COVID-19 pandemic, randomized serological surveys have been conducted at varying scales in the United States across the states of California, Georgia, Indiana, Kentucky, Oregon, and Rhode Island, but with narrow temporal resolution. 4, [7] [8] [9] [10] Although such a snapshot measure of cumulative infection in a narrow window of serology is an accurate way to estimate past prevalence of infection in communities, the lack of repeated measurements reduces the utility of such results for relating to wastewater measures. Wastewater results are not cumulative and change over time, and as such discrete wastewater measurements may fail to identify changes in the infection rates or to identify small recalcitrant refugia of infection in discrete geographic hot spots. In contrast, longitudinal stratified sampling could provide robust estimates required to evaluate the fidelity of wastewater measurements.

Previous combined wastewater and serological surveys at a community scale have focused on Hepatitis A and E viruses. 11, 12 Existing SARS-CoV-2 wastewater to community COVID-19 case models have been fit around results obtained from convenience sampling, models which may underrepresent community trends, [13] [14] [15] [16] [17] as well as limited random samples of communities via SARS-CoV-2 in nasal swabs 10 or blood bank serological surveys. 15, 18 Nonetheless, robust longitudinal estimates of community serology are more appropriate to interpret wastewater measurements. 4 The purpose of the current study was to evaluate the nature of wastewater measurements of SARS-CoV-2 in relation to community COVID-19 prevalence, adjusted for geographical and demographic variables. To accomplish this, we compared the rates of SARS-CoV-2 infection obtained from serial, stratified random serological samples in conjunction with serial sampling of virus levels in community wastewater. Using statistical prevalence modeling adjusted for both uncertainty in seropositivity measurements as well as for heterogeneity in temporal and spatial epidemic trends, we evaluated the correspondence between wastewater viral levels and estimates of community prevalence obtained through randomized stratified clinical sampling. The simultaneous analysis of these contemporaneous data sets enabled a quantitative comparison of both sampling approaches. We believe that this approach represents the most reliable and economical monitoring and surveillance program for an infectious agent attempted to date.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint 2. Methods 2.1 Probability temporal seroprevalence of COVID-19: The study area was the Louisville/Jefferson County metropolitan area in Kentucky (KY), USA, which has a population of approximately 767,000 individuals and represents the largest urban population center in Kentucky. Four probability designed testing waves lasting approximately a week were conducted. The waves were separated by one to three months. Households were sampled using an address-based sampling frame derived from US Postal Service delivery files. 19 For each wave between 18,000 to 36,000 invitations to participate in the study were mailed to the addresses and the sampled adult was asked to complete a screening interview and schedule an appointment for testing. 20, 21 Some of the sewershed dynamics have been provided in previously published reports. [21] [22] [23] The five subpopulations jointly comprise approximately 97% of the county population. This allowed for the capture and separation of different wastewater regions within the larger county (see Figure 1 ). See Supplement C for details. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint 2.4 Estimating COVID-19 prevalence based on community seroprevalence testing: Serostatus was determined as a qualitative assessment by measuring levels of SARS-CoV-2 spike protein specific immunoglobulin (Ig) G (Spike IgG) antibodies in peripheral blood samples as reported previously by Hamorsky et al. 24 Seroprevalence can detect the antibodies of COVID-19 patients up to 300 days following infection. 25, 26 There was a low number of participants positive for Spike IgG antibodies for the individual areas of MSD3, MSD4 and MSD5 (MSD3-5 N=31 participants positive) ( Table 1) . To ensure proper balance of the demographic profiles of the subpopulation in the stratified analysis, the data from the three smallest areas were pooled together resulting in three spatial strata.

The model used for estimating prevalence from seropositivity, referred below as SIRT, is a modification of the classical Susceptible, Infected, Recovered (SIR) ecological model of an epidemic 27 with an additional compartment (denoted T) for seropositive. The tracking of seropositivity status appears necessary as most individuals do not build detectable levels of antibodies until sometime after the infection. 25 The SIRT model uses a system of ordinary differential equations (ODEs) to describe time evolution of the proportions of susceptible (S), infected (I), removed (R), and seropositive (T) individuals in a large population. See Supplement D for details.

To apply the SIRT model for estimating prevalence, we adapted the ODE-based survival analysis method proposed recently. 28 Following KhudaBukhsh et al., 28 we treat ODEs trajectories S t, I t , R t , T t as respective probabilities that a randomly selected individual from large population is, at time t, susceptible, infected, recovered, or seropositive. In this model, we considered the results of all individual antibody-based tests conducted at time t as independent binary variables with probability of a positive test given by T t * = T t +(1-spe)(1-T t ) where spe is the specificity level of the diagnostic test (100% sensitivity level of the test is assumed). Given that at time t, n t individuals are tested with k t testing positive, the corresponding log-likelihood function is LL t (θ) ∝ k t log T t *+(n t -k t ) log(1-T t *) where θ denotes the vector of SIRT model parameters to be estimated. We use the Bayesian Markov chain Monte-Carlo method for estimating θ, to properly capture prior information and to account for various sources of uncertainty. With estimated values of the parameters available, we can apply the SIRT model ODEs to calculate average estimated prevalence over time.

2.5 Correspondence between estimates of SARS-CoV-2 prevalence from community seroprevalence testing sampling and wastewater measurements: Using contemporaneous wastewater concentration and estimated prevalence, we derived a regression-based correspondence model between the average wastewater concentration and the average prevalence of COVID-19 in Jefferson County both in aggregate and stratified by sewersheds locations. The prevalence rates were calculated based on the SIRT model estimates, with census data and geocoding techniques used to estimate the actual infection counts by sewersheds. The analysis was based on the linear regression model for prevalence rate and on a negative binomial regression for infection counts. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint the University of Louisville Institutional Review Board classified this as non-human subjects research (reference #: 717950).

Role of the funding source: The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint Table 1 shows the number of adults tested and the percent who were positive for SARS-CoV-2 Spike IgG antibodies in the four waves of data collection by the three areas and the SIRT model estimated values of average seroprevalence and prevalence in cases per 100K people. The estimates of average seroprevalence appear to largely follow the pattern of empirical values, increasing over different testing waves, as more individuals first got infected and acquired antibodies to the virus. Note; however, that this is not the pattern of the model-based prevalence estimates presented in the last column. Indeed, the estimates of prevalence indicated by wave four the epidemic was already declining in MSD1 but still expanding in MSD3 to MSD5 that experienced overall higher average prevalence during the testing period than other sewersheds. In Figure 2 we present the model-based prevalence predictions (left panels) as well as the aggregated and stratified model-based seroprevalence fit (right panels). The different prevalence trends both in terms of epidemics peaks sizes and timings in different sewersheds (marked by red lines) are clearly visible in the plots.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint dots). Solid red line is the model-estimated prevalence. Shaded area corresponds to 95% credibility bounds. Right (red) panels: Percent seroprevalence in study participants is shown as black dots indicating sample-size weighted observation, and the red line is the best fit of the model median prediction. Shaded area corresponds to the 95% credible interval.

3.2 Correspondence between estimated prevalence and wastewater concentration SARS-CoV-2 was detected in 90% of the wastewater samples. The stratified serial plots of their mean weekly concentrations are shown in the left panels of Figure 2 , superimposed on the corresponding prevalence estimates. The community wastewater concentrations and prevalence estimates show good qualitative agreement over time. To quantify the extent of agreement, we performed two types of Bayesian regression analysis. In the first analysis, we regressed the aggregate and stratified SIRT model estimates of percentage prevalence on the wastewater concentrations via simple linear regression. In the second, we used the Bayesian negative binomial (NB) regression model and regressed the model-predicted prevalence counts on the same set of wastewater abundance. The respective data and model predictions are shown in Figure 3 , using weekly aggregated data for better visualization.

For the pooled data from Jefferson County (top left panel), the results of a simple linear regression model showed a strong correlation of 0·63 (posterior CI = (0·32, 0·84)) between the prevalence of SARS-CoV-2 and average wastewater SARS-CoV-2 concentration. In the aggregate linear regression model (top right panel), the estimated slope coefficient corresponds to relative prevalence increase of 1·27 cases per 100K people (posterior CI = (0·67, 1·88)), for every unit increase in the wastewater concentration. The rates for different watershed areas are listed in Table 2 . Similar results were obtained from NB regression, which is more appropriate for directly modeling infection counts. For aggregated data, the NB regression model (top right panel) gives the log-scale regression coefficient to be 0·0097 (posterior CI = (0·00452, 0·151)) corresponding to the prevalence increase of about 1·01 case per 100K people for one unit increase in wastewater concentration. The remaining sewershed zone rates from the NB regression are given in Table 2 . All Bayesian regression models are based on flat (noninformative) prior distributions for the model parameters.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint Table 2 : Values of posterior means derived from regression analysis of prevalence versus mean wastewater concentrations (see Figure 3 ). The posterior means for simple and NB regressions are based on MCMC analysis (see supplemental D material).

Linear regression model NB regression model

Posterior slope (95% credibility interval)

Posterior slope (95% credibility interval)

In addition to comparing our SIRT-based prevalence estimates with the observed wastewater concentrations of SARS-CoV-2, we have also compared the SIRT-based incidence estimates with publicly reported COVID-19 cases in Jefferson County. The weekly counts were chosen to smooth the administrative reporting variability and weekend reporting delays. The results of our analysis suggest that, as expected, the model-based incidence estimates obtained from the observed seropositivity rates in four waves of testing were significantly higher than the official incidence. The ratio of our model-estimated to officially reported cases was found as, respectively, 1·47, 1·14, 1·48, and 1·80 for the pooled county data and when stratified by sewershed areas MSD1, MSD2, and MSD3 to 5 (Supplement D).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

Wastewater-based epidemiology (WBE) has emerged as a rapid, convenient, and economical approach for assessing the prevalence of viral infections in communities. However, WBE estimates lack external validation and it is unclear how well virus levels in wastewater correspond to community-wide prevalence of infection. In this study, we examined the relationship between wastewater SARS-CoV-2 concentration and the prevalence of infection in the community. Rather than using direct official rates, which are subject to bias due to convenience sampling, we estimated the prevalence of infection by repeated measurements of seropositivity in randomized sampling of area population. We developed models for bothestimates of community prevalence and wastewater concentration. The wastewater data correspond well to community prevalence. Combined analyses of these models indicate that one unit prevalence increase in wastewater concentration corresponds to 1 case per 100K people.

A comparison of the administratively-reported COVID-19 cases with our model suggests convenience sampling significantly underestimates the rates of infection in the community. However, the extent of underestimation varied among different sewersheds from a ratio of 1·14 to 1·80. This is similar to the geographical trends in wastewater results for these sewerzones, which are also variable. 22 Although other research purports a transfer function relating wastewater measures and clinical prevalence is possible, 15, 16, 18 it has not been quantified before. Xiao et al. 17 suggests a ratio of wastewater viral copy numbers to reported COVID-19 cases (WC ratio) which changes over time, whereas our model adapts over time but with a consistent transfer function. Moreover, our results do not support a linear relationship between wastewater and prevalence proposed by Layton et al. 10 and Cao et al. 13 Previous convenience seroprevalence studies paired to wastewater may have underreported the correlation, owing to inadequate or no case data from portions of a community, underreporting of at-home COVID-19 antigen rapid self-test results, and reliance on clinical syndromic surveillance. Hoar et al. 14 have suggested that a log10 change in the SARS-CoV-2 viral load in wastewater corresponds to a 0·6 log10 change in the number of new laboratory-confirmed COVID-19 new cases/day in a sewershed. Although their model focuses on predicting new cases and hence is not directly comparable with ours, we find a qualitative agreement between both models.

The utility of SARS-CoV-2 Spike IgG antibodies to estimate community-wide prevalence of infection observed in our study is consistent with previous work. 6 The use of systematic serological surveys for calibrating wastewater measurements removes much of the selection bias observed in previous relationships. [13] [14] [15] [16] [17] Although seropositivity provides estimates of past infection, an increase in seropositivity over a defined period is likely to be a reliable indicator of the spread of infection. Hence, over the course of the eight-month project, enriched contextual data were provided to city decision makers and stakeholders to inform long-term trends in infection rates as well as the levels of SARS-CoV-2 in local wastewater. The environmental data provided by wastewater sampling when compared with data obtained from in person exams allowed for the development of comprehensive, internally-validated data sets for assessing the trajectory of COVID-19 in the community and for the identification of geographically-defined subpopulations where the virus was lingering. As approximately 97% of the population of Jefferson County, KY uses the sewage system, there measurements of SARS-CoV-2 abundance in the wastewater is largely representative of the community, which, when coupled with a randomized population-based seroprevalence sampling strategy, makes this an ideal dataset for . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint estimating the correspondence between estimates of seroprevalence and WBE. Both our wastewater and randomized seroprevalence have a wide temporal window of capture. While the model was developed from data obtained by using anti-spike protein antibodies in unvaccinated populations, it could be readily modified for vaccinated communities by using anti-N-protein antibodies.

The major strength of this approach is the repeated, randomized sampling design to estimate community-wide changes in seroprevalence paired with frequent wastewater sampling concentration changes, which enabled us to make a mathematical function that models how the inputs relate to each other. To our knowledge, this is the only effort to pair randomized longitudinal seroprevalence with wastewater to-date. The robust coupling of probability-based serological results with wastewater measurements underscores the utility of this approach, not only for cross-validation of each estimate, but also to provide reliable data to support public health decisions. Hence, the findings reported here could form the basis of additional in-depth investigations as it outlines an efficacious approach to follow changes in infection rates in specific geographic areas within a large metropolitan area. Finally, although reported here for SARS-CoV-2 infection, the approach could also be readily extended to the measurement and validation of other viruses and bacteria, as well as other wastewater analytes such as pharmaceutical or xenobiotic metabolites.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

Despite its many strengths, this study has some limitations. The shedding rate and duration by COVID-19 infected persons is highly individual. 2 Both seroprevalence and wastewater are a measure of a portion of the community that has been infected, not necessarily active infections. Our seroprevalence study design only considered an adult population, while wastewater included the entire community population using flush toilets in the county (likely in the range of 2+ years old). Wastewater sampling excluded anyone not connected to the piped infrastructure, such as residents on septic-tanks. We also did not consider the fecal shedding rate in our model. The broader generalization of the specific modeled relationship may be affected by sewer-system dependent factors that are not fully understood. 29 For example, the wastewater matrix includes complex chemistry and structural specifics which may affect the amount of virus that is recoverable. Replication in other locations would greatly assist in identifying the contribution of such differences.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

In this study, we proposed a novel analytical model to predict disease prevalence of SARS-CoV-2 using systematic retrospective serological surveys with spatiotemporal resolution making a direct comparison of concentrations of viral RNA in wastewater to disease prevalence at a subcommunity scale possible. Because we used a community-wide random sampling approach, it is likely that our survey design model has less biased underlying data than previous studies based entirely on convenience sampling, as it was less susceptible to underreporting of community infections and therefore more comparable to the population shedding into wastewater. Our spatial estimates were in good agreement with corresponding data on SARS-CoV-2 wastewater concentrations. Our findings indicate that wastewater data could be used as a surrogate of COVID-19 prevalence as well as the prevalence of other pathogens.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Contributors AB, TS, KEP and RK conceived and developed the idea for the study. KEP supervised the serology assays; ABS and KK performed the serology assays, performed quality control assessments, and uploaded the data to the redcap database. TS and RH supervised the wastewater analyses. GAR performed the model-based data analyses, which was supported by CAR, KB, and BC. RHH wrote the first draft of the manuscript with all authors contributing to the interpretation of data and critical revision of the article. MB accessed and verified the data reported in the study. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

The seroprevalence and wastewater data used in the study can be accessed at https://github.com/cbskust/Seroprevalene.COVID19. The computer code implementing our model-based analysis will be made available immediately following publication. The code will be shared with researchers who provide a methodologically sound proposal approved by GAR and AB. Proposals should be directed to rempala.3@osu.edu and aruni.bhatnagar@louisville.edu; requesters will need to sign a data access agreement.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

Individuals 18 and up were randomly recruited from eight sampling sectors covering the entirety of the county, in total 123,213 adults were invited, and 3,792 participants enrolled. The invited sample included about 16% more minority participants than an equal allocation. Differential response rates are typical in many household surveys, with lower rates of responding associated with high density and non-white households when the primary recruitment method is by the internet. The oversampling of the minority population resulted in a sample of minorities closer to the Louisville/Jefferson County population proportion. The sampling fraction was 3,792/767,419 or 0·49%. At a mobile testing site, nose swabs were acquired to test for COVID-19 infection by PCR and blood was collected for assessing seropositivity. Demographic information including sex, race, age, and address were noted along with vaccination status and location (given as sewerzone). 1 The team informed each participant of their infection and immunity status by letter. Under the assumption that infection-derived antibodies do not wain to undetectable levels during this analysis the percent positivity of the antibody tests by day acts as a single estimate for seroprevalence on that day.

All households in Louisville/Jefferson County were stratified into 8 sectors roughly proportional to the sector size (population) based on the census block group of the address. In the first four waves of the probability sample (June 2020 to February 2021), a sample of between 2,000 and 3,000 households was selected in each sector (the sampling procedure changed for later waves) using an address list derived from United States Postal Service delivery files. 2 Each selected household was mailed an invitation to participate in the study in which the sampled adult (18 years or older) was asked to complete an online informed consent, screening, and survey questions, and schedule an appointment for clinical testing. With the mailed invitations, each household of the probability sample population was provided with a unique personal identification registration code to be entered at the time of online registration, thereby allowing the investigators to differentiate between probability and convenience sampling populations. Each household was contacted multiple times to encourage participation. Though a convenience sample was also recruited, the data are not included in the analysis here. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

Louisville/Jefferson County reported daily COVID-19 infected individuals by street address by date from July 6, 2020, to February 28, 2021, were provided by the Louisville/Jefferson County Information Consortium and Louisville Metro Department of Public Health and Wellness under a Data Transfer Agreement. Data prior to July 2020 was not reliable. First, locator software was used to automatically assign longitude and latitude coordinates to addresses. For those not able to be automatically assigned, records missing street address information and those with an address outside the county were excluded, and remaining records were manually reviewed. Records with only zip codes for an address were probabilistically assigned to census blocks based on population weighting within each block of that zip code, and records were then assigned the location of the center of the census block. Geocoding was conducted maintaining Health Insurance Portability and Accountability Act (HIPAA), using ArcGIS Pro version 2·8·0 (Redlands, CA). 7-day totals were used to offset effects of clinical testing artifacts such as reporting lags were calculated of new COVID-19 cases based on testing in each of the five-water quality treatment plant zones. In total N= 65,038 publicly reported COVID-19 cases in Louisville/Jefferson County were able to be assigned to the five sewerzones by week.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

Influent wastewater samples were obtained from five water quality treatment plants corresponding to the sampling sectors once to four times per week for the presence and the concentration of SARS-CoV-2. The five subpopulations jointly comprise approximately 97% of the county population. This allowed capture and separation of the different county wastewater regions, samples (N=244) were collected from August 17, 2020, to February 28, 2021, with the exception sampling was interrupted the last two weeks of December. Samples were collected by the Louisville/Jefferson County Metropolitan Sewer District (MSD) using an automated 24-h time-weighted composite sampler. Samples were transported on ice to the University of Louisville for analysis. SARS-CoV-2 in collected samples was quantified in triplicate by reverse transcription polymerase chain reaction (RT-qPCR) with polyethylene glycol (PEG) precipitation. 1 Samples were processed within 12 h of collection. Data for SARS-CoV-2 (N1) is reported in copies/ml of wastewater for this work. The threshold value, as recommended by Klymus et al. 2 for N1 assays was 7·5 copies/ml. Figure C1 : Flow chart of August 2020 to February 2021 of the Co-Immunity COVID-19 wastewater study data. 26 se . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

Chance Alvarado, Krzysztof Banecki, Boseung Choi and Grzegorz A. Rempala

The statistical analysis model that allows us to relate serial seropositivity data to both the rates of incidence and prevalence of SARS-CoV-2 in Jefferson County is based on the classical SIR ecological model of disease 1 with an additional compartment, T. The rationale behind this compartment is that individuals do not build detectable levels of antibodies for some period after infection. 2 Below, we refer to this modified model as SIRT. Model fitting and parameter estimation for SIRT and the related regression models was conducted through the Stan statistical modeling platform 3 integrated into R 4 via the Rstan and Rstanarm library. 5 We specifically used Stan to implement a robust hamiltonian Markov chain Monte Carlo (MCMC) algorithm to find posterior probability distributions for model parameters. The final estimates were based on 4000 samples (after burn-in 2000 samples) from converged samplers with Rubin statistic R used to measure convergence based on two independent chains. 5

The equation shown in (1) where ݀ corresponds to a specific day of interest. The estimated prediction counts were obtained by multiplying the rates in P r e d ௧ by the appropriate population numbers.

To relate our SIRT model predictions to serial wastewater measurements of SARS-CoV-2 concentrations, we performed Bayesian linear regression and negative binomial regression based on both the county aggregated data and data stratified by sewershed area. To improve regression model stability, we used cumulative weekly incidence counts from SIRT model as the outcome variable and weekly aggregated average wastewater concentrations as the single explanatory variable. Although the water flow rate adjustment was initially performed, the effect of this adjustment was seen as statistically insignificant, and it was not included in the final model (see Figure S4 ). In the Bayesian linear regression models, we assigned non-informative priors. Specifically, nob-informative Cauchy distribution was assigned to regression coefficients and non-informative gamma prior was assigned to the dispersion parameter of the error term. In the Bayesian negative binomial regression model, we similarly assigned non-informative normal priors to regression coefficients and non-informative exponential priors to the dispersion parameter. The summary of the posterior estimates of all regression parameters is presented in . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint Table S3 below and the slope parameters summaries are additionally listed in Table 2 in the main body of the paper. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint Figure D4 : Scatter plots of the sewershed specific flow rates vs average concentrations of wastewater SARS-CoV-2 (N1) (copies/ml). The plots indicate no visible correlation between flow rates and wastewater concentration measurements.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 1, 2022. ; https://doi.org/10.1101/2022.04.28.22274086 doi: medRxiv preprint

SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases

Prevalence and persistent shedding of fecal SARS-CoV-2 RNA in patients with COVID-19 infection: A systematic review and meta-analysis

Spatial inequities in COVID-19 testing, positivity, confirmed cases, and mortality in 3 US Cities: An ecological study

Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing

Use of serological surveys to generate key insights into the changing global landscape of infectious disease

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Seroprevalence of SARS-CoV-2 antibodies in Rhode Island from a statewide random sample

Population point prevalence of SARS-CoV-2 infection based on a statewide random sample-Indiana

Clinical infectious diseases: an official publication of the Infectious Diseases Society of America

Wastewater-based epidemiology predicts COVID-19 community prevalence

First detection of hepatitis E virus in Central Argentina: Environmental and serological survey

Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance

On forecasting the community-level COVID-19 cases from the concentration of SARS-CoV-2 in wastewater

Monitoring SARS-CoV-2 in wastewater during New York City's second wave of COVID-19: sewershed-level trends and relationships to publicly available clinical testing data

A Wastewater-Based Epidemic Model for SARS-CoV-2 with Application to Three Canadian Cities

Longitudinal monitoring of SARS-CoV-2 in wastewater using viral genetic markers and the estimation of unconfirmed COVID-19 cases

Metrics to relate COVID-19 wastewater data to clinical testing dynamics

COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar

The changing role of address-based sampling in survey research

The rapid assessment of aggregated wastewater samples for genomic surveillance of SARS-CoV-2 on a city-wide scale

Wastewater sample site selection to estimate geographically resolved community prevalence of COVID 19: A sampling protocol perspective

SARS-CoV-2 RNA abundance in wastewater as a function of distinct urban sewershed size

Surveillance of RNase P, PMMoV, and CrAssphage in wastewater as indicators of human fecal concentration across urban sewer neighborhoods

Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky

A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States

Centers for Disease Control and Prevention. Interim guidelines for COVID-19 antibody testing

The Kermack-McKendrick epidemic model revisited

A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States

R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing

R: A language and environment for statistical computing. R Foundation for Statistical Computing

RStan: the R interface to Stan

Survival dynamical systems: individual-level survival analysis from population-level epidemic models

Funding: This work was supported by a contract by the Centers for Disease Control, the Louisville-Jefferson County Metro Government as a component of the Coronavirus Aid, Relief, and Economic Security Act, as well as grants from the James Graham Brown Foundation and the Owsley Brown II Family Foundation. Serology work was also supported in part by the Jewish Heritage Fund and the Center for Predictive Medicine for Biodefense and Emerging Infectious Disease. We thank the Louisville/Jefferson County Metropolitan Sewer District for their valuable collaboration in wastewater sample collection.

where all quantities are assumed to be non-negative.To obtain the serial estimates of incidence and prevalence from the observed seropositivity levels in four waves of testing, we adapt the idea of an ODE-based survival model proposed recently in KhudaBukhsh et al. 6 where) is a vector of parameters to be estimated.Given the testing data at where ‫‬ ሺ ߠ) is the prior distribution on ߠ as given in Table 2 in the next section. Hence, we seek the values ofthat maximize our posterior log-likelihood function (3) . Note that for each parameter combination, the entire system (1) must be solved. Here, this system is solved with a fourth and fifth order Runge-Kutta method.

Posterior serial estimates of the relative rates of incidence, prevalence, and seropositivity were obtained from the SIRT model as the time-dependent vector